COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT02083484
Brief Title: Program for Pembrolizumab (MK-3475) in Participants With Metastatic Melanoma Who Have Failed Standard of Care Therapy Including Ipilimumab (MK-3475-030)

First Submitted : March 7, 2014
First Submitted that Met QC Criteria : March 7, 2014
First Posted : March 11, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : January 25, 2018
Last Update Posted : January 26, 2018